" Unlocking Nature's Secrets"™ Newsletter     |     About Us    |     Contact Us
       
  investors  
 

SEC Filings
Press Release
Media
From the President’s Desk

Grow with your investment

The project is the first botanical extraction business in South Africa addressing the issues of unprofitable tea estates by making them viable through the harvesting of fresh green tea leaf for the sole purpose of extracting a bioavailable green tea gallate catechin extract.

"The dynamic growth of this industry using formulated green tea extracts as alternative medicine or as a synergistic combination therapy with pre-existing antiviral or antibiotics depends on a method of delivery that ensures its stability and greater bioavailability. Green tea and green tea extracts are one of the most researched agents in the natural botanical sector, with over 20 years of investigations supporting five hundred research studies published identifying markets and final products that deliver benefits in weight loss, anti-aging, treating diabetes 1 & 2, blood cholesterol lowering, treating high blood pressure, and relieving symptoms of certain cancers and malaria. The market for green tea is in a high growth stage with increasing annual volume growth rates between 13-14 percent. (Frost & Sullivan Research, 2011).

Plandaí Biotechnology is the culmination of over 15 years of R&D in the field of plant extracts. Its principle holdings consist of land, farms and infrastructure, totalling more than 7500 acres, in the province of Mpumalanga, South Africa.

Company snapshot

Site designed and maintained by Cantaloupe Digital